CVKD
Cadrenal Therapeutics, Inc.
0.9723$
-1.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -21.3% | -13.6% | +0.2% | +1,255.5% | -92.7% | +0.0% | +38.4% | +0.0% | -9.2% | – | |
| – | -32.6% | +57.8% | +18.7% | +55.3% | +154.4% | -28.1% | +8.0% | -20.1% | -31.3% | -22.4% | +166.3% | – | |
| – | +35.7% | -197.2% | – | -114.0% | – | -183.1% | – | -399.8% | – | -629.1% | – | – | |
| – | +325,400.0% | -100.0% | – | – | – | -50.3% | +0.1% | -43.1% | +75.7% | -99.9% | -100.0% | – | |
| – | – | – | – | – | – | -50.3% | – | -157.0% | +75.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.2% | – | -100.0% | – | +387.7% | -73.6% | -36.0% | -48.6% | +319.2% | -52.1% | +77.5% | – | |
| – | -112.0% | – | – | – | – | -147.4% | – | – | – | -1,250.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.